164 related articles for article (PubMed ID: 15610070)
1. The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans.
Böhm F; Settergren M; Gonon AT; Pernow J
Clin Sci (Lond); 2005 Apr; 108(4):357-63. PubMed ID: 15610070
[TBL] [Abstract][Full Text] [Related]
2. L-arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivo.
Pernow J; Bohm F; Beltran E; Gonon A
J Appl Physiol (1985); 2003 Dec; 95(6):2218-22. PubMed ID: 12937030
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig.
Wang QD; Li XS; Lundberg JM; Pernow J
Cardiovasc Res; 1995 Jun; 29(6):805-12. PubMed ID: 7656284
[TBL] [Abstract][Full Text] [Related]
4. Moderate, Short-Term, Local Hyperglycemia Attenuates Forearm Endothelium-Dependent Vasodilation After Transient Ischemia-Reperfusion in Human Volunteers.
Ebert TJ; Novalija J; Barney JA; Uhrich TD; Arain SR; Freed JK; Pagel PS
J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1649-1655. PubMed ID: 28284926
[TBL] [Abstract][Full Text] [Related]
5. Ticagrelor mitigates ischaemia-reperfusion induced vascular endothelial dysfunction in healthy young males - a randomized, single-blinded study.
Weisshaar S; Litschauer B; Eipeldauer M; Hobl EL; Wolzt M
Br J Clin Pharmacol; 2017 Dec; 83(12):2651-2660. PubMed ID: 28715608
[TBL] [Abstract][Full Text] [Related]
6. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
Tack CJ; Ong MK; Lutterman JA; Smits P
Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion.
Pleiner J; Schaller G; Mittermayer F; Marsik C; MacAllister RJ; Kapiotis S; Ziegler S; Ferlitsch A; Wolzt M
Atherosclerosis; 2008 Mar; 197(1):383-91. PubMed ID: 17645881
[TBL] [Abstract][Full Text] [Related]
8. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.
Richard V; Kaeffer N; Hogie M; Tron C; Blanc T; Thuillez C
Br J Pharmacol; 1994 Nov; 113(3):869-76. PubMed ID: 7858879
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis.
Böhm F; Ahlborg G; Pernow J
Clin Sci (Lond); 2002 Mar; 102(3):321-7. PubMed ID: 11869173
[TBL] [Abstract][Full Text] [Related]
10. L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease.
Settergren M; Böhm F; Malmström RE; Channon KM; Pernow J
Atherosclerosis; 2009 May; 204(1):73-8. PubMed ID: 18849028
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin combined with ticagrelor prevent ischemia-reperfusion induced vascular endothelial dysfunction in healthy young males - A randomized, placebo-controlled, double-blinded study.
Weisshaar S; Litschauer B; Kerbel T; Wolzt M
Int J Cardiol; 2018 Mar; 255():1-7. PubMed ID: 29288055
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats.
Singh AD; Amit S; Kumar OS; Rajan M; Mukesh N
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):604-10. PubMed ID: 16700825
[TBL] [Abstract][Full Text] [Related]
13. The nonpeptide endothelin receptor antagonist bosentan enhances myocardial recovery and endothelial function during reperfusion of the ischemic rat heart.
Wang QD; Li XS; Pernow J
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S445-7. PubMed ID: 8587441
[TBL] [Abstract][Full Text] [Related]
14. (6R)-5,6,7,8-tetrahydro-L-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm.
Mayahi L; Heales S; Owen D; Casas JP; Harris J; MacAllister RJ; Hingorani AD
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1334-9. PubMed ID: 17413035
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin does not mediate remote ischaemic preconditioning or ischaemia-reperfusion injury in vivo in man.
Pedersen CM; Schmidt MR; Barnes G; Bøtker HE; Kharbanda RK; Newby DE; Cruden NL
Heart; 2011 Nov; 97(22):1857-61. PubMed ID: 21873443
[TBL] [Abstract][Full Text] [Related]
16. Reperfusion injury in the human forearm is mild and not attenuated by short-term ischaemic preconditioning.
Kilian JG; Nakhla S; Griffith K; Harmer J; Skilton M; Celermajer DS
Clin Exp Pharmacol Physiol; 2005; 32(1-2):86-90. PubMed ID: 15730440
[TBL] [Abstract][Full Text] [Related]
17. Postconditioning protects against human endothelial ischaemia-reperfusion injury via subtype-specific KATP channel activation and is mimicked by inhibition of the mitochondrial permeability transition pore.
Okorie MI; Bhavsar DD; Ridout D; Charakida M; Deanfield JE; Loukogeorgakis SP; MacAllister RJ
Eur Heart J; 2011 May; 32(10):1266-74. PubMed ID: 21362704
[TBL] [Abstract][Full Text] [Related]
18. Greater functional ETB receptor antagonism with bosentan than sitaxsentan in healthy men.
MacIntyre IM; Dhaun N; Lilitkarntakul P; Melville V; Goddard J; Webb DJ
Hypertension; 2010 Jun; 55(6):1406-11. PubMed ID: 20404221
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin gene-related peptide-induced vasodilation in the human forearm is antagonized by CGRP8-37: evaluation of a human in vivo pharmacodynamic model.
Vanmolkot FH; Van der Schueren BJ; de Hoon JN
Clin Pharmacol Ther; 2006 Mar; 79(3):263-73. PubMed ID: 16513450
[TBL] [Abstract][Full Text] [Related]
20. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis.
Sfikakis PP; Papamichael C; Stamatelopoulos KS; Tousoulis D; Fragiadaki KG; Katsichti P; Stefanadis C; Mavrikakis M
Arthritis Rheum; 2007 Jun; 56(6):1985-93. PubMed ID: 17530638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
